CRISPR-targeting produced a point mutation that results in the amino acid substitution of glutamic acid with lysine at position 1132 (E1132K), which is equivalent to E1124 in human patients with midline brain defects. (J:296537)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count